Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review.
Curr Psychiatry Rep
; 23(11): 71, 2021 10 06.
Article
in English
| MEDLINE | ID: covidwho-1453879
ABSTRACT
PURPOSE OF REVIEW This systematic review evaluated the impact of the COVID-19 pandemic on obsessive-compulsive symptoms. RECENT FINDINGS:
Most studies showed that obsessive-compulsive symptoms worsened during the early stages of the pandemic, particularly for individuals with contamination-related obsessive-compulsive disorder (OCD), though other symptoms dimensions were found to worsen as well. Many patients and individuals in the general population experienced new obsessive-compulsive-like symptoms centered on COVID-19. Self-reported rates of symptom exacerbation and COVID-19-focused symptoms were consistently lower in studies that recruited patients from specialty clinics (compared to online samples). Most studies were conducted in Spring/Summer, 2020. The COVID-19 pandemic has been an enormous stressor for individuals with OCD, especially for those with contamination symptoms. Regardless, there is strong reason to believe gold standard treatment approaches for OCD have maintained strong efficacy. Disseminating and effectively delivering evidence-based treatments for OCD is an urgent public health priority.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Obsessive-Compulsive Disorder
Type of study:
Experimental Studies
/
Observational study
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
Language:
English
Journal:
Curr Psychiatry Rep
Journal subject:
Psychiatry
Year:
2021
Document Type:
Article
Affiliation country:
S11920-021-01284-2
Similar
MEDLINE
...
LILACS
LIS